Cargando…
Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort
BACKGROUND: In 2011, Rwanda became the first African nation to implement a national human papillomavirus (HPV) vaccination program, conceived to protect girls aged <15 years (i.e. born ≥1997). After an initial school-grade-targeted catch-up campaign, there was a transition to routine vaccination...
Autores principales: | Sayinzoga, Felix, Umulisa, M. Chantal, Sibomana, Hassan, Tenet, Vanessa, Baussano, Iacopo, Clifford, Gary M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221340/ https://www.ncbi.nlm.nih.gov/pubmed/32336599 http://dx.doi.org/10.1016/j.vaccine.2020.04.021 |
Ejemplares similares
-
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys
por: Sayinzoga, Felix, et al.
Publicado: (2023) -
Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan
por: Baussano, Iacopo, et al.
Publicado: (2021) -
Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda
por: Umulisa, M. Chantal, et al.
Publicado: (2018) -
Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme
por: Ngabo, Fidele, et al.
Publicado: (2016) -
Human papillomavirus genotypes in cervical and other HPV‐related anogenital cancer in Rwanda, according to HIV status
por: Mpunga, Tharcisse, et al.
Publicado: (2019)